HEPATIC δ-AMINOLÆVULINIC ACID SYNTHETASE ACTIVITY IN PORPHYRIA CUTANEA TARDA

[1]  Abe Goldberg,et al.  Recent Advances In Haematology , 1971 .

[2]  P. Lundin,et al.  Iron storage in porphyria cutanea tarda. , 2009, Acta medica Scandinavica.

[3]  H. Marver,et al.  Biochemical defects in two types of human hepatic porphyria. , 1970, The New England journal of medicine.

[4]  S. Hernberg,et al.  Enzyme inhibition by lead under normal urban conditions. , 1970, Lancet.

[5]  A. Weinfeld,et al.  Studies of the clinical and metabolic effects of phlebotomy treatment in porphyria cutanea tarda. , 2009, Acta medica Scandinavica.

[6]  J. Epstein,et al.  Porphyria cutanea tarda. A study of the effect of phlebotomy. , 1968, The New England journal of medicine.

[7]  S. Zail,et al.  Hepatic δ‐Aminolaevulinic Acid Synthetase Activity in Symptomatic Porphyria , 1968 .

[8]  P. Mustard,et al.  Delta-aminolaevulinic acid synthetase activity in normal and porphyric human livers. , 1967, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[9]  R. Levere.  Stilbestrol-Induced Porphyria: Increase in Hepatic δ-Aminolevulinic Acid Synthetase , 1966 .

[10]  L. Wasserman,et al.  Coated charcoal assay of unsaturated iron-binding capacity. , 1966, The Journal of laboratory and clinical medicine.

[11]  S. Granick,et al.  The induction in vitro of the synthesis of delta-aminolevulinic acid synthetase in chemical porphyria: a response to certain drugs, sex hormones, and foreign chemicals. , 1966, The Journal of biological chemistry.

[12]  D. Young,et al.  Method for the automatic determination of serum iron , 1965, Journal of clinical pathology.

[13]  S. O. Berlin,et al.  IRON METABOLISM IN PORPHYRIA AND HÆMOCHROMATOSIS , 1962 .